Pulmonary resection for metastases from colorectal cancer

Chest

Volumn 119, Issue 4, 2001, Pages 1069-1072

  Sakamoto, T ^a   Tsubota, N ^a   Iwanaga, K ^a   Yuki, T ^a   Matsuoka, H ^a   Yoshimura, M ^a  

^a HYOGO MEDICAL CENTER FOR ADULTS   (Japan)

Author keywords

Carcinoembryonic antigen; Colorectal cancer; Lung metastases; Prognosis; Surgical resection

Indexed keywords

CARCINOEMBRYONIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; COLORECTAL CARCINOMA; COLORECTAL SURGERY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; LIVER METASTASIS; LUNG METASTASIS; LUNG RESECTION; MALE; PRIORITY JOURNAL; PROGNOSIS; THORACOTOMY;

EID: 0034920251     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.119.4.1069     Document Type: Article

References (18)

1. The surgical treatment of metastatic tumors in the lung
2. Nonparametric estimation from incomplete observations
3. Asymptotically efficient rank and invariant procedures
4. Colorectal lung metastases: Results of surgical excision
5. Failure in resection of multiple pulmonary metastases from colorectal cancer
6. Pulmonary resection for metastatic colorectal cancer: Experiences with 159 patients
7. Surgery for lung metastases from colorectal cancer: Analysis of prognostic factors
8. Current management of colorectal metastases to lung
9. Resection of pulmonary metastases from colorectal carcinoma
10. Pulmonary resection for metastases of colorectal origin
11. Resection of both hepatic and pulmonary metastases in patients with colorectal carcinoma
12. Surgical treatment of hepatic and pulmonary metastases from colorectal cancers
13. Cascade spread of blood-borne metastases in solid and nonsolid cancers of human
14. Long-term results after repeated surgical removal of pulmonary metastases
15. Biology of human colon cancer metastasis
16. 5-Fluorouracil and low-dose leucovorin in metastatic colorectal cancer: A pilot study
17. Phase II study of CPT-11, a new camptothecin derivative, in metastatic colorectal cancer
18. Irinotecan is an active agent in untreated patients with metastatic colorectal cancer